(Q35566335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Antonello Petrella

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Romano MF

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Bisogni R

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Tassone P

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Venuta S

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

11-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403171

20 December 2019

exact match

0 references

cites work

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Cellular stress response and apoptosis in cancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Aberrant rel/nfkb genes and activity in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

NF-kappaB at the crossroads of life and death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Suppression of apoptosis: role in cell growth and neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

NF-kappaB as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

The generation of nfkb2 p52: mechanism and efficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Is NF-kappaB2/p100 a direct activator of programmed cell death?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Bcl-3/IgH translocation (14;19)(q32;q13) in non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

1 reference

7 January 2021

Interchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-kappa B/Rel- specific decoy oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Preferential induction of apoptosis for primary human leukemic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Effect of NF-kappaB/Rel inhibition on spontaneous vs chemotherapy-induced apoptosis in AML and normal cord blood CD34+ cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Antisense technologies. Improvement through novel chemical modifications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Proteasome inhibition: a novel approach to cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Nucleocytoplasmic transport: the soluble phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence/structure analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Hematopoietic cytokines, transcription factors and lineage commitment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Transcriptional cross talk between NF-kappaB and p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Validating survivin as a cancer therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Internal ribosome initiation of translation and the control of cell death.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

NF-kappaB signals induce the expression of c-FLIP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Repression of GADD153/CHOP by NF-kappaB: a possible cellular defense against endoplasmic reticulum stress-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Identification of polymorphisms of the IkappaBalpha gene associated with an increased risk of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

NF-kappa B as a therapeutic target in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Transcription factors as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403171

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14574329%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference